Empagliflozin vs Gefitinib

Empagliflozin vs Gefitinib: Overview

This comparison examines the pharmacological differences between Empagliflozin and Gefitinib.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Gefitinib — 48 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Gefitinib — C22H24ClFN4O3.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Gefitinib — 446.9000 g/mol.

Type: Empagliflozin — Small molecule; Gefitinib — Small molecule.